Related Experiment Video
Updated: Nov 1, 2025

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
Moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) modulates protein aggregation
Surbhi Chaudhary1, Asmita Dhiman1, Anil Patidar1
1Institute of Microbial Technology, CSIR, Sector 39A, Chandigarh 160036, India.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents protein aggregation by interacting with misfolded cytosolic prion (cyPrP) and huntingtin (httQ-103). Overexpressing GAPDH reduces detectable protein aggregates, highlighting its role in maintaining protein solubility.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Protein misfolding and aggregation are linked to cellular dysfunction and disease.
- The cellular machinery normally prevents aggregation, but failures lead to pathological states.
- Cytosolic prion (cyPrP) and huntingtin (httQ-103) are aggregation-prone proteins implicated in neurodegenerative diseases.
Purpose of the Study:
- To investigate the interaction between aggregation-prone proteins and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
- To determine if GAPDH influences the aggregation state of cyPrP and httQ-103.
- To elucidate the role of GAPDH in cellular protein homeostasis.
Main Methods:
- Förster Resonance Energy Transfer (FRET) based analysis.
- Biochemical assays to detect protein aggregation.
- Cellular overexpression of GAPDH.
Main Results:
- FRET and biochemical data show that cyPrP and httQ-103 interact with GAPDH.
- Overexpression of GAPDH significantly reduces the formation of detectable protein aggregates.
- GAPDH demonstrates a protective effect against the aggregation of heterogeneous proteins.
Conclusions:
- GAPDH actively participates in shielding and maintaining the solubility of aggregation-prone proteins like cyPrP and httQ-103.
- This abundant cytoplasmic protein plays a crucial role in cellular protein quality control.
- Targeting GAPDH function may offer therapeutic strategies for protein aggregation diseases.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Protein Folding Quality Check in the RER
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation

